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Abstract
Background: Aphasia affects the ability to speak, comprehend spoken language, read and write. One third of
stroke survivors experience aphasia. Evidence suggests that aphasia can continue to improve after the first few
months with intensive speech and language therapy, which is frequently beyond what resources allow. The
development of computer software for language practice provides an opportunity for self-managed therapy. This
pragmatic randomised controlled trial will investigate the clinical and cost effectiveness of a computerised approach
to long-term aphasia therapy post stroke.
Methods/Design: A total of 285 adults with aphasia at least four months post stroke will be randomly allocated to
either usual care, computerised intervention in addition to usual care or attention and activity control in addition to
usual care. Those in the intervention group will receive six months of self-managed word finding practice on their
home computer with monthly face-to-face support from a volunteer/assistant. Those in the attention control group
will receive puzzle activities, supplemented by monthly telephone calls.
Study delivery will be coordinated by 20 speech and language therapy departments across the United Kingdom.
Outcome measures will be made at baseline, six, nine and 12 months after randomisation by blinded speech and
language therapist assessors. Primary outcomes are the change in number of words (of personal relevance) named
correctly at six months and improvement in functional conversation. Primary outcomes will be analysed using a
Hochberg testing procedure. Significance will be declared if differences in both word retrieval and functional
conversation at six months are significant at the 5% level, or if either comparison is significant at 2.5%. A cost utility
analysis will be undertaken from the NHS and personal social service perspective. Differences between costs and
quality-adjusted life years in the three groups will be described and the incremental cost effectiveness ratio will be
calculated. Treatment fidelity will be monitored.
Discussion: This is the first fully powered trial of the clinical and cost effectiveness of computerised aphasia
therapy. Specific challenges in designing the protocol are considered.
Trial registration: Registered with Current Controlled Trials ISRCTN68798818 on 18 February 2014.
Keywords: Speech and language therapy, Aphasia, Computerised intervention, Self-management, Long term
rehabilitation, RCT design, Stroke
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Background
Stroke is the largest cause of disability in the United
Kingdom with communication impairment affecting one
third of survivors [1]. Aphasia is the most common
communication impairment acquired post stroke. It is a
disorder of language which may affect understanding,
expression, reading and writing. Speech and language
therapy (SLT) is often received regularly initially but rarely
continues after the first few months. Medical instability,
fatigue and confusion may reduce full engagement with
language therapy in the early weeks post stroke, reducing
the opportunity for people to participate in treatment.
There is evidence that people can continue to improve
their language skills for several years [2]. As the conse-
quences of aphasia remain a problem long term, investiga-
tion of interventions to reduce this health burden in the
chronic stages post stroke is crucial. The National Stroke
Strategy [1] recommends people receive rehabilitation for
as long as they benefit from it. Treatment of aphasia
that persists beyond the first few months post stroke is
often not available through NHS services in the United
Kingdom as ongoing therapy is costly through face-to-face
SLT and places greater demands on limited resources.
Meta-analysis in a Cochrane review [2] of SLT for
aphasia following stroke suggests some effectiveness of
aphasia therapy [2]. Adequately powered randomized
controlled trials (RCTs) in this field are rare except for
recent studies of SLT intervention in the first few weeks
post stroke. Laska et al. [3] randomised 123 patients with
aphasia to receive 45 minutes of SLT a day for 21 days,
starting within two days of stroke onset, or no SLT
intervention. Severity of the aphasia was not reduced.
A recently completed study, ACT NoW [4], randomised
170 people in hospital post stroke to SLT intervention or
attention control (informal conversation with paid visi-
tors) for up to four months. No significant differences be-
tween groups were shown and the authors suggested that
the intervention may have been provided too early in the
stroke pathway. As aphasia persists for many stroke survi-
vors, therapy in the longer term also warrants investiga-
tion using adequately powered RCTs. Although rapid
spontaneous recovery may occur in the first few months,
there is preliminary evidence to suggest targeted and in-
tensive SLT treatments can promote further improvement
in the latter months [5-7].
Targeted therapies with good preliminary evidence to
date include constraint induced aphasia therapy (CIAT);
use of language in games to make, reject or clarify re-
quests for targeted items for 30 hours over 2 weeks
[5,8,9]. A systematic review of 10 studies conducted over
the decade concluded that evidence for this technique is
favourable [10]. Model oriented aphasia therapy (MOAT),
which tailors treatment according to a patient’s individual
symptoms, was found to be comparable to CIAT when
delivered with similar intensity [11]. Raymer et al. found
personal relevance or ‘salience’ of the language material be-
ing practiced to be important when targeting therapy [6].
While the optimum intensity remains unclear, it is gener-
ally acknowledged that for stroke rehabilitation regular, re-
petitive therapy practice is a factor in treatment success.
The resources required to achieve intensive therapy in
the long term is prohibitive in the current financial cli-
mate and lower cost options for the support of repetitive
intensive practice are needed. Non-speech and language
therapy professionals have been employed successfully
to support therapy activity [4,12,13].
Computer therapy, developed for the treatment of apha-
sia, has been reported to be useful in the provision of tar-
geted language practice and provides opportunities for
independent home practice as part of a self-management
approach to maximise practice intensity, improving
outcomes for reading, spelling and expressive lan-
guage [13-17]. The Department of Health report, ‘Our
Health, Our Care, Our Say’ [18], recommends self-
management for long term conditions supported through
technological innovation [18]. However, to date, studies of
self-managed computer therapy for aphasia have been
limited to descriptive case series with only three reported
RCTs; two for treatment of reading disorders and one for
treatment of word finding [13,14,19]. Although these
studies were not fully powered, they indicate potential
effectiveness of computer therapy. Such computer-based
services for long term management of aphasia therapy
could provide a low cost therapy option which is accept-
able to patients and families. However, the actual cost ef-
fectiveness has not been definitively tested.
The StepbyStep© computerised approach to long term
aphasia therapy combines current evidence underpin-
ning language therapy with practical considerations of
treatment delivery. Skills of a qualified speech and lan-
guage therapist are used to select individually targeted
therapy exercises, computer software is provided for regu-
lar self-managed practice of therapy exercises and volun-
teers or assistant SLTs support language practice and
computer use [20]. A pilot study evaluating this approach
was carried out with 34 people with persistent aphasia.
They were randomly assigned to using computer software
designed for treating aphasia, or usual long term care
(most frequently this was social support). On average
people with aphasia practiced their speech exercises on
the computer independently for 25 hours over five
months. The therapy showed statistically significant
improvement in the ability to use spoken words when
compared to usual care (P = 0.014). The results indi-
cated that self-managed computer therapy supported
by volunteers (a total of four hours on average) could help
people with aphasia to continue to practise, improving
their vocabulary and confidence talking [13]. Patients and
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carers found it an acceptable alternative to face-to-face
therapy [21]. Self-managed computer therapy could there-
fore improve the quality of life of people with persistent
aphasia at relatively low cost, and exploratory economic
analysis has suggested considerable potential for the inter-
vention to prove cost effective [13,22].
The aim of this study is to provide definitive evidence of
the clinical and cost effectiveness of targeted, intensive
speech and language impairment-based therapy interven-
tion for word finding delivered through self-managed
computer exercise for persisting post-stroke aphasia. This
builds on the pilot RCT which explored possible effects,
and informed measures, feasibility, recruitment rates, ad-
herence, cost effectiveness analysis and a power calcula-
tion. The current study was commissioned by the United
Kingdom National Institute for Health Research, having
considered the limitations in the current evidence base.
Objectives
The primary objectives of the study are:
1. To establish whether self-managed computerised
speech and language therapy for aphasia related
word finding problems after stroke increases the
ability to use vocabulary of personal importance
(impairment).
2. To establish whether self-managed computerised speech
and language therapy for word finding problems after
stroke improves functional communication ability in
conversation (activity).
3. To investigate whether patients receiving self-managed
computerised speech and language therapy perceive
greater changes in social participation and quality of
life (participation).
4. To establish whether self-managed computerised
speech and language therapy is cost effective for
persistent aphasia post stroke.
5. To identify whether any effects of the intervention
are evident 12 months after therapy has begun.
Secondary objectives include investigating the generalisa-
tion of treatment to retrieval of untreated words (impair-
ment); the use of treated words in conversation; the carer
perception of communication effectiveness (participation)
and identification of any possible adverse events. Carers’
own quality of life will be measured. Fidelity to treatment
will also be monitored.
Methods/Design
Design
The study will use a pragmatic, parallel group randomised
controlled adjunct trial design. The intervention under test
or attention control will be delivered in addition to usual
care. Outcomes will be compared for people who are four
months or more post stroke, with persistent aphasia who
are randomly allocated to either: usual care, self-managed
computerised speech and language therapy in addition to
usual care or attention control in addition to usual care.
Each participant will be in the trial for 12 months. Partic-
ipants will be identified and recruited over an 18-month
period in total, and 15 months at each site. Each partici-
pant will receive their intervention for six months, with
follow-up at six, nine and 12 months. The study has an in-
ternal pilot phase with criteria for progression to comple-
tion of the full RCT. There are no formal statistical criteria
for stopping the trial early. Decisions to stop the trial early
on grounds of safety or futility will be made by inde-
pendent data management and ethics committee mem-
bers. The protocol conforms to the Consolidated Standards
of Reporting Trials (CONSORT) guidelines for non-
pharmacological studies (Figure 1) [23].
Ethics approval
The study protocol was approved by Leeds West research
ethics committee (reference number: 13/YH/0377). Add-
itional approval was granted for Scotland by the Scotland
A research ethics committee (reference number: 14/SS/
0023). The University of Sheffield is the sponsor. The trial
is registered with the International Standard Randomised
Controlled Trials database ISRCTN (reference number:
68798818) and is commissioned by the National Institute
for Health Research.
Participants
A total of 285 participants who have a diagnosis of apha-
sia as a consequence of a stroke will be recruited from
approximately 20 speech and language therapy depart-
ments across the United Kingdom. The study will also
be advertised at voluntary groups and using posters in
libraries and GP surgeries in each locality so that potential
participants can self-present to the local research team.
Inclusion criteria
Participants will be included if they meet the following
criteria:
1. Aged 18 or over;
2. Diagnosis of stroke(s);
3. Onset of stroke at least four months prior to
randomisation;
4. Diagnosis of aphasia, subsequent to stroke, as
confirmed by a trained speech and language therapist;
5. Ability to retrieve 10 to 90% of words on the
Comprehensive Aphasia Test Naming Objects
subtest (score of 5 to 43 out of 48);
6. Ability to perform a simple matching task in
StepByStep with at least 50% accuracy (to confirm
sufficient vision and cognitive ability) and
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Figure 1 Progression of participants through the trial (CONSORT diagram). SLT = speech and language therapist; ITT = intention to treat.
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7. Ability to repeat at least 50% of words in a simple
word repetition task in the StepByStep© program.
Exclusion criteria
Participants will be excluded from the study if they meet
any of the following criteria:
1. They have another pre-morbid speech and
language disorder caused by a neurological deficit
other than stroke (a formal diagnosis can be
reported by the participant or relatives and
confirmed by the recruiting speech and language
therapist).
2. They require treatment for a language other than
English (as the software is in English).
3. They are currently using the StepbyStep© computer
programme or other computer speech therapy
aimed at word retrieval and/or naming.
Procedures
Identification
Potential participants will be contacted by the research
speech and language therapist in each project centre and
provided with information on the project. They will be
contacted within a fortnight to establish whether they
are interested in knowing more about the study. If they
are interested, the research speech and language therap-
ist will make an appointment to visit them at home. The
number of those contacted but who cannot be followed
up on or who are not interested in learning more and
the reason for this will be recorded.
Screening for eligibility
Eligibility will be established on the first visit. The speech
and language therapist will request verbal consent to carry
out the Naming Objects subtest of the Comprehensive
Aphasia Test [24]. This test is used in routine practice and
will establish the severity of the word finding deficit. If the
word finding score is less than 10%, or greater than 90%,
an explanation will be given that this type of computer
therapy is not suitable for them. If the potential partici-
pant has eligible word finding scores, the research speech
and language therapist will ask them to try a simple repe-
tition task to confirm their repetition ability, followed by a
matching task on the computer to confirm ability to see
the screen and perform simple computer related actions.
Recruitment
The level of support required to enable a person with
aphasia to provide informed consent is dependent upon
the severity and profile of the aphasia. In order to pro-
vide information in a format consistent with each indi-
vidual's language ability, a consent support tool (CST)
will be used [25]. The research speech and language
therapist at each site will request verbal consent from
the potential participant to carry out part A of the CST.
The result will indicate the style of information they are
most likely to understand in part B. Participants will be
given sufficient time to consider their participation be-
fore informed consent is taken by a research speech and
language therapist. Participants providing their own in-
formed consent will be provided with an aphasia-friendly
consent form. If potential participants with severe aphasia
indicate an interest, a relative (in Scotland this will be the
person’s legal representative or nearest relative) will be
asked to read an information sheet detailing their respon-
sibility, and will be asked to sign a carer declaration on be-
half of their relative with aphasia (in Scotland they will be
asked to sign a consent form). For those participants with
a carer, the carer will be asked if they are willing to
complete some outcome measures related to their own
quality of life and perception of their relative’s commu-
nication ability. They will be provided with the carer
information sheet detailing their potential involvement and
will be asked to sign a separate consent form. Informed
consent will be obtained from each participant where they
are able to give it, or consent or carer declaration will be
obtained by the carer or legal representative where the par-
ticipant is interested in participating, but is unable to pro-
vide their own fully informed consent.
Baseline assessment
Initial assessment will be performed by the local re-
search speech and language therapist once informed
consent has been given. This will include collection of
the following demographic data: aphasia type, age, gen-
der, time post-onset of stroke and type and location of
stroke (if known). Baseline information will also include
results of the standardised naming test - Naming Objects
subtest of the Comprehensive Aphasia Test (performed as
part of eligibility testing during screening) and the Com-
prehension of Spoken Sentences subtest of the CAT to
provide information on the comprehension ability of the
participants [24]. Baseline measures relating to the study
outcomes are summarised in Table 1.
Outcome measures
Primary
1. Change in the number of words (personally relevant
to the participant) named correctly at 6 months
from baseline will be measured by a naming task of
100 pictures presented on the computer.
2. Change in functional communication will be measured
by blinded ratings of video-recorded conversations
between unfamiliar speech and language therapists
blinded to treatment allocation and participants at
six months. Conversations will be structured around
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topics of personal relevance to the participants by the
speech and language therapist performing an
assessment to ensure the sensitivity of the measure.
The same topic guide will be followed by blinded
speech and language therapists performing outcome
measures. Independent speech and language therapists
blinded to treatment allocation and measurement time
point will rate the videoed conversations at the project
coordinating centre using the activity scale of the
Therapy Outcome Measures (TOMS) [26].
Key secondary
Improvement in patient perception of communication
will be measured using the Communication Outcomes
After Stroke (COAST) questionnaire at six months - a
patient-centred, patient-reported measure of commu-
nication related activity, participation and quality of
life [27].
Other secondary
Evidence of treatment effect will be measured by repeat-
ing all outcome measures at nine and 12 months from
baseline, in addition to the primary end point of 6 months.
The nine-month time point is included as an interim
measure as drop out from the study was found to increase
over time in the pilot study [13].
Generalisation of treatment to retrieval of untreated
words will be measured using the Naming Objects subtest
from the Comprehensive Aphasia Test. Carer perception
of communication effectiveness will be measured using
the Carer COAST questionnaire [28]. Carer quality of life
will be measured using the last five items of the Carer
COAST questionnaire [28] and the CarerQol question-
naire [29]. Negative effects of treatment will be reported
through diaries. Table 1 summarises the main measures
and methods of data collection. Follow-up assessments
will be conducted within one month of the target time
point.
Randomisation, blinding and allocation concealment
Following baseline assessment, the participant will be
randomised to one of the three trial intervention arms.
Randomisation will be performed by an online random-
isation system developed and maintained through the
Sheffield Clinical Trials Research Unit (CTRU). The ran-
domisation sequence will be generated in advance by the
trial statistician. Randomisation will be stratified by
centre (as heterogeneity between centres is expected),
and according to severity of word retrieval at baseline,
based on percentage scores on the Naming Objects sub-
test of the Comprehensive Aphasia Test (severe = 10 to
34%, moderate = 35 to 64%, and mild = 65 to 90%). The
Table 1 Summary of measures
Outcome Measure Method of collection
Change in word finding ability Naming of 100 personally relevant words Taken at baseline by blinded SLT recruiting
participant 6, 9 and 12 months by separate
blinded SLT.
Change in functional communication 10-minute videoed conversations structured
around topics of personal interest. Activity
scale of TOMS used to measure conversational
ability
Conversations at baseline by blinded SLT.
Separate blinded SLT follows same topic
guide at 6, 9 and 12 months. Videos
randomised and rated centrally by blinded
assessors.
Change in patient perception of
communication and quality of life
COAST self-reported questionnaire. Administered by blinded SLT at baseline.
Separate blinded SLT at 6, 9, and 12 months.
Generalisation to untreated words Naming Objects subtest from Comprehensive
Aphasia Test
As above
QALYs for cost effectiveness EQ-5D for patient and carer (accessible and by proxy) As above
Carer quality of life Carer COAST and CarerQol Self-administered
Cost of intervention Diaries of time spent on intervention Self-administered by SLTs, SLTAs and volunteers
Cost of usual care Diaries of time spent on usual care SLT collects data from usual treating therapists and
participants at baseline, 3, 6, 9 and 12 months
Carer perception of change in
communication
Carer COAST Collected by blinded SLT at baseline. Separate
blinded SLT at 6, 9, and 12 months.
Negative effects of treatment Patient diary to record any difficulties and/or negative
impacts of intervention
Patients and carers - central team to send monthly
letter reminding to send back in prepaid envelope.
Intervention adherence Software tailoring checklists. Volunteer and/or
assistant feedback forms. Software key files. Puzzle
book and telephone support feedback.
Completed by SLT, monitored by central study team.
Self-managed practice monitored by central study
team. Puzzle book completion and telephone support
recorded by member of central study team.
SLT = speech and language therapist; TOMS = Therapy Outcome Measures; COAST = Communication Outcomes After Stroke questionnaire; SLTA speech and
language therapy assistant.
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research speech and language therapist will then inform
the participant which group they have been allocated to
and draw their attention to the description of this group
in the information sheet.
Blinding
This is a single blind study. The patient participants are
not blind to their treatment allocation. The speech and
language therapists performing baseline assessments will
do this prior to randomisation. A second speech and
language therapist at each site, blinded to group alloca-
tion, will perform follow-up assessments. The speech
and language therapist setting up the treatment will ask
participants not to discuss treatment with the person
coming to carry out the follow-up measures. It is pos-
sible that unblinding will happen during conversation
and the speech and language therapists will be asked to
record instances of this. A primary outcome is func-
tional communication in conversation. Video recordings
of conversations will be presented in random order to
speech and language therapists in the project coordinat-
ing centre to rate, blind to treatment allocation and
follow-up time. The chief investigator, study manager,
statisticians and health economist will all be blind to
group allocation.
Interventions
Usual care control arm Usual care for this pragmatic
study may consist of participation in a range of activities
to a greater or lesser extent. Usual care varies across the
country in terms of type, frequency and length of provision,
and is dependent upon available resources in each locality.
Findings from the pilot study confirmed that usual care for
four months or more following a stroke may include: face-
to-face speech and language therapy targeting language im-
pairment (reading, writing, speaking or understanding);
therapy focussing on compensatory communication strat-
egies, provision of communication aids or psychological
support; attendance at voluntary support groups or infor-
mal communication support from family and friends. Usual
care will be recorded retrospectively for three months prior
to the study and throughout the study on the case report
forms for all groups. Those who are randomised to the usual
care group will not receive any project specific intervention.
Self-managed computerised therapy intervention A
structured intervention is proposed in addition to usual
care as tested in the pilot study. The intervention targets
word retrieval as it is one of the challenges most fre-
quently experienced by people with aphasia, restricting
their communication. The three components of the inter-
vention are as follows:
Qualified speech and language therapist assessment,
tailoring of exercises and monitoring
The speech and language therapist at each site will
tailor computer exercises to the individual using 100
words of personal relevance chosen by the participant.
Photographs imaging the 100 words will be selected
from those existing in the software, or can be added
from a digital camera or from image stores on a
computer. The computer software (StepbyStep© by
Steps Consulting Ltd, Gloucester, UK) [30] enables the
speech and language therapist to select exercises using
these words that follow steps in the therapy process
that the therapist would take if delivering it face to
face. The speech and language therapist bases the
selection of exercises on language skills demonstrated
in the initial language assessments. The speech and
language therapist will provide initial demonstration of
the software exercises, check that the individual is able
to use the software and monitor the appropriateness of
the tailored exercises. This is expected to take only
three to four hours, based on the pilot study [13], as
the computer intervention is predominantly self-managed
by the patient.
Regular self-managed practice
The participant will then be asked to work through the
exercises on the computer and be encouraged to
practise each day for 20 to 30 minutes. Participants will
be given a six-month period to work though the therapy
material on the computer and practise using the new
vocabulary in their daily lives. As this is a pragmatic
trial, those participants who have the software installed
on their own computers will not be prevented from
continuing to practise if they wish, following the six-month
supported intervention time. Any continued use of
software beyond the six months will be recorded.
Volunteer support to assist with treatment adherence
and carry over into daily activity
To enhance treatment adherence, the speech and
language therapist will provide training to local
volunteers who already have a working relationship
with the SLT department or SLT assistants based in the
department. They will use the three-hour training
programme and instruction book (University of
Sheffield, Sheffield, UK) developed and evaluated
during the pilot study. The volunteer will be asked
to visit the participant once a month for an hour, or
every two weeks for half an hour (to suit the patient),
carrying out the following tasks: provide technical
assistance; observe and encourage use of computer
exercises; check results and discuss difficulties; assist
the participant to move on to harder tasks in the
therapy process pre-programmed by the speech and
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language therapist; encourage the use of new words
in everyday situations, conversation and discussions
with family about how to encourage use and encourage
re-use of completed exercises over time.
The participants will be able to contact the volunteer
or SLTA by telephone for technical advice on computer
use between planned visits if necessary. Volunteers and
SLTAs will be asked to complete a feedback form on
each face-to-face session with a participant and send it
to the therapist to enable them to provide tailored
advice and support. They therapists are also encouraged
to meet with all the volunteers/SLTAs together every two
months for support and discussion of issues arising.
The majority of the practice time involved in the
intervention is self-managed by the participant through
regular use of the aphasia computer software. The
therapists, SLTAs and volunteers will be asked to
keep diaries of resource use showing direct and indir-
ect (telephone and computer set up) time spent and
therapist grade (see Table 1).
Attention and activity control arm The third group in
this study intends to control for the potential impact of ele-
ments of the intervention which of themselves do not pro-
vide or require specific speech and language intervention.
Participants randomised to this arm will be provided
with generalised activities to carry out and general atten-
tion in addition to usual care. On allocation to this
group, the speech and language therapists conducting
baseline assessments will provide books of standard puz-
zles that can be purchased from most supermarkets or
high street shops. Each book will contain enough activ-
ities for one to be carried out each day for at least a
month. Examples of puzzles include getting through a
maze, spotting the difference between pictures, matching
objects that are the same, word searches, Sudoku and so
forth. The SLT will provide age appropriate puzzle books
that match the participant’s linguistic ability as indicated
by the baseline assessments. Puzzle books will be colour
coded into levels of easy, medium and hard by the clini-
cians on the research team centrally and a leaflet will be
provided to give speech and language therapists guid-
ance on skills required for each level.
A member of the research team will contact the par-
ticipants or their carer by telephone or email (whichever
is preferred by the participant) once a month to provide
the attention similar to that given by volunteers in the
intervention arm. They will ask if they are enjoying the
activities, how many they have managed to do, whether
they would like a new puzzle book sent to them for the
coming month and whether they would like the same
level of difficulty or an easier or harder one. The partici-
pants will also have access to these contact details to en-
able them to ask for easier or harder books at any time
if necessary, again, mimicking the access to the volun-
teers and SLTAs and type of attention available in the
intervention arm.
Treatment fidelity
The speech and language therapists delivering this inter-
vention will receive training on how to set up appropriate
exercise steps. To enable monitoring of the treatment fi-
delity, they will be asked to complete a checklist which
guides their selection of exercises based on the participant
language profile identified during assessment. These will
be reviewed centrally by the study quality monitor.
Encrypted and anonymised key files from the partici-
pants’ software will be returned to the study team to
enable comparison of a random selection of exercises
provided with the corresponding checklist completed.
As this is a self-managed intervention, adherence of
the participants in using the intervention as intended
will be monitored. This will be achieved through volun-
teer or assistant visits with reminders to practise daily
and assistance with using the full range of exercises set.
The speech and language therapist will also monitor
practice through feedback forms provided by the volun-
teer or assistant. In addition, the software key files
returned to the study coordinating team centrally will be
reviewed for total practice time and patterns of practice
over the six-month treatment period. Practice with the
computer for a minimum of 20 minutes three times a
week at home on average will be considered per protocol
to account for periods of illness and holiday. Volunteer
and assistant adherence will be monitored through their
feedback forms to the speech and language therapists
who will record amounts of support provided. A mini-
mum of four hours in total per patient will be consid-
ered per protocol. Adherence to the attention control
group will be monitored by recording information re-
garding the number of puzzles completed and the fre-
quency and duration of telephone support calls received.
Usual care will be recorded across the study period for
all groups.
Data and statistical analysis
Sample size The study aims to recruit 285 participants
across 20 speech and language therapy departments
(study sites and centres). The sample size of 285 patients
in total (95 per arm) is the maximum sample size esti-
mate across the two primary endpoints (word finding
ability and functional conversation ability) and key sec-
ondary endpoint (patient perception of communication
ability) for 90% power and a two-sided significance level
of 5%.
Assumptions for the sample size calculation For im-
provement in word retrieval the estimated effect size is
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10%, with a standard deviation (SD) of 17.38%, from an
analysis of covariance (based on results of the pilot study
[13]). For assessment of conversation the estimated ef-
fect size is 0.45 of a SD (with a correlation between
baseline and outcome of 0.5 previously observed in the
ACT NoW study). For patient-rated improvement using
the COAST questionnaire the estimated effect size is
7.2, with a standard deviation (SD) of 13.5 (with an as-
sumed correlation between baseline and outcome of 0.5).
The observed dropout rate was 5 out of 33 (15%; 95% CI: 5
to 32%) in the pilot study, which translated to a completion
rate of 28/33 (85%; 95% CI: 68 to 95%) [31].
Internal pilot
The initial phase of the study will be conducted as an in-
ternal pilot trial and will include clear criteria to inform de-
cisions about progression. Data from the internal pilot will
be included in the final analysis. The internal pilot trial will
be limited to six sites (over 25% of the total), representative
of the sites which will be in the substantive study. However,
during this phase we will recruit and commence set-up
processes for all the intended sites. The progression criteria
will be reviewed eight months from site set-up of the sixth
site in the internal pilot trial. We are estimating that this
will be approximately halfway through the recruitment
phase, at 22 months from contract start.
The progression will be based on achieving the follow-
ing criteria: recruitment of no fewer than 30 participants
(10% of the target for the full trial), a minimum partici-
pant retention rate of 65%, 80% of participants having
been offered a volunteer and 70% of participants con-
tinuing to be supported by the same volunteer for their
six-month treatment period.
Statistical analysis
Patients with at least one post-randomisation observa-
tion will be included in the analysis. Missing data will be
described using summary statistics. Data will be checked
and cleaned blind to the actual treatment allocation. Data
checking will be conducted throughout the study and
prior to any analysis of the data.
Primary and key secondary endpoints for the compari-
sons of control to intervention and active control to
intervention will be analysed using a Hochberg testing
procedure, which allows for an investigation of all three
endpoints whilst maintaining the overall type I error at
5% [32]. This approach has the advantage of not inflat-
ing the sample size while maintaining the type I error
rate at 5%.
Significance will be declared for the comparison of
usual care to intervention if and only if both primary
outcomes, word retrieval and conversation, are signifi-
cant at the 5% level, or if either comparison is significant
at 2.5%. If and only if significance is declared for both
primary outcomes, a similar comparison of attention
control to intervention will be made. Significance will be
declared for the comparison of attention control to inter-
vention if and only if both word retrieval and conversation
are significant at the 5% level, or if either comparison is
significant at 2.5%.
If and only if significance is declared for the comparison
of attention control to intervention for both comparisons
will the key secondary outcome measure (patient percep-
tion of communication and related quality of life, mea-
sured using the COAST rating scale) be used in a further
comparison of usual care to intervention. If and only if
this comparison is significant at the 5% level will the inter-
vention be compared to attention control based on the
COAST questionnaire (see Figure 2).
Primary analysis will take an intention-to-treat approach
(ITT) for all key measures, and further exploratory ana-
lysis of participants who complied with the intervention
will be undertaken using the same statistical tests, accord-
ing to the per protocol principle (PP). Only patients with
post-randomisation observations will be included in the
primary analysis at six months. A sensitivity analysis re-
sponses will be imputed as appropriate with details pro-
vided in the statistical analysis plan.
Figure 2 Statistical testing procedure. COAST = Communication Outcomes After Stroke questionnaire.
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The mean difference in percentage improvement of
words named correctly between the treatment and con-
trol groups, adjusted for baseline naming ability, will be
analysed using an analysis of covariance (ANCOVA).
Terms for treatment and baseline will be fitted into the
model. Assumptions underlying the analyses will be
assessed by inspection of residual plots. Homogeneity of
variance will be assessed by plotting the studentised re-
siduals against the predicted values from the model,
whilst Normality will be assessed by use of Normal
probability plots. If the assumptions for the analysis of
variance are violated then appropriate transformations
may be applied or alternative analyses may be performed.
Similar analyses will be undertaken for the endpoints of
functional conversation ability (measured by the activity
scale of the Therapy Outcome Measures and patient-
reported communication outcomes (the COAST ques-
tionnaire). The endpoints at nine and 12 months will be
similarly analysed for exploratory purposes. Likewise an
investigation of trends over time will be made.
Health economic analysis
A cost utility analysis will be undertaken from the NHS
and personal social service (PSS) perspective. Due to the
use of volunteers to help participants with their use of
the computer program we will undertake a supplemen-
tary analysis taking a societal perspective. Costs will be
estimated for individual patients, including intervention
costs and SLT support and coordination time (collected
through diaries as shown in Table 1), combined with
standard costing sources [33]. In the pilot study we col-
lected other resource use data (on, for example, GP and
hospital visits and prescribed medications) via patient
and carer diaries, but these did not show important dif-
ferences between treatment groups and we will not col-
lect such data in the full trial. The EQ-5D questionnaire
will be administered at every data collection time point
(see Table 1) and will be combined with standard valu-
ation sources to measure the QALYs gained in each
treatment arm [34]. An accessible version of the EQ-5D
designed for people with aphasia was trialled in the pilot
study. This has not been validated but represents a way
in which EQ-5D scores can be elicited directly from pa-
tients. We will administer this version of the EQ-5D
alongside the standard version which will be completed
by carers (where the participant has a carer) by proxy.
EQ-5D and CarerQoL scores will also be elicited from
carers (Table 1).
We developed a Markov model to estimate the cost ef-
fectiveness of the computer intervention alongside our
previous pilot study. Model parameters were informed
by clinical data from the trial. We estimated that the
intervention was likely to be cost effective, with an in-
cremental cost effectiveness ratio (ICER) of £3,058 per
QALY gained, however results were uncertain and the
value of obtaining further (perfect) information was very
high (expected value of perfect information (EVPI) was
approximately £37 million). This model will be updated
with data from the full trial. The third attention control
group will be added to the model. Differences between
costs and QALYs in the three groups will be described
and an incremental analysis will be performed with
ICERs calculated. Probabilistic sensitivity analysis will
be undertaken to allow the production of cost effect-
iveness acceptability curves [33] and value of informa-
tion analyses [35].
Quality monitoring
The speech and language therapists carrying out out-
come measures will receive training on how to deliver
the assessments reliably, including scoring criteria and
benchmarking of scoring video-recorded assessments
with other assessors. Site monitoring visits will also be
carried out within the first six months of recruitment
(and more frequently if required) to check accurate
completion of case report forms, adherence to the
protocol for taking consent and discussion of any is-
sues arising.
Discussion
Chronic aphasia has a considerable impact on a person’s
ability to participate in many personal, social and work
activities. Despite evidence of the potential for continued
language improvement over time with intensive practice
of targeted, salient language therapy exercises, opportun-
ities to participate in such ongoing therapy are limited
due to resource pressures. There is preliminary evidence
of the potential for computer software developed for
aphasia therapy to provide new opportunities for on-
going aphasia therapy for patients to participate in for as
long as they wish and/or benefit. Indeed, there is an in-
crease in the software options being developed for inde-
pendent language practice. In order for health services
or private practitioners and the public to invest in this
option it is crucial to know whether such interventions
are clinically and cost effective. This protocol describes
the first fully powered RCT of long term aphasia therapy
delivered through self-managed computerised language
exercises, with the support of volunteers or assistants.
The protocol also describes the process for the first full
economic analysis of a computerised aphasia intervention.
The therapy under investigation is a complex interven-
tion of word finding therapy for aphasia. Previous stud-
ies, including the pilot study informing this protocol,
have shown that people with aphasia learn the words
that are meaningful to them more successfully than
those they have little functional need for. As in many re-
habilitation interventions, this therapy is driven by the
Palmer et al. Trials  (2015) 16:18 Page 10 of 12
patient’s own goals. Communication needs to achieve
different goals are discussed with the therapist and a
range of words key to achieving those goals are identi-
fied. The personalisation of the therapy goals requires
some personalisation in the measurement of whether
they have been achieved. The design of outcome mea-
sures which can be used to make group comparisons
whilst maintaining accurate measurement of individual
goals was a challenge. Discussions resulted in two pri-
mary outcome measures. The first measures word find-
ing ability whereby all participants have comparable
word finding scores from naming 100 pictures. Measure-
ment of word finding of personally meaningful and use-
ful words is achieved by allowing the 100 words to be
different for each individual according to their goals.
Similarly, the second measures ability to communicate
in conversation. All conversations are rated using the ac-
tivity scale of the TOMS so group comparisons can be
made. Measurement of individual goals is maintained by
structuring the conversations around the communication
areas identified as personally relevant by each individual.
Other key issues in designing the protocol arose from
the pragmatic nature of the study. First of all, in order to
recruit sufficient numbers of participants, at least 20
speech and language departments are required across
the United Kingdom. This will allow generalisation of
the results to the population of the United Kingdom.
However, we expect considerable variation in the usual
care provided to people with aphasia in the long term
post stroke, with some sites providing impairment based
interventions face to face for several months, and others
limiting their service provision to hospital care or for a
few weeks post-hospital discharge only. The intervention
being tested could be implemented in addition to any
existing services in practice. The study therefore uses
an adjunct design whereby patients continue to receive
any ongoing care. This may have the added benefit of
recruiting those patients who would not wish to be
randomised away from usual care. To account for the
heterogeneity expected, the randomisation is to be
stratified by site, ensuring representation of different
models of usual care in each study group.
There are challenges in involving people with aphasia
in research, as they often have difficulty reading or un-
derstanding spoken language. The protocol for obtaining
informed consent therefore needed careful consideration.
In order to adhere to the Mental Capacity Act (2005) in
England and the Adults with Incapacity Act (2000) in
Scotland, a consent support tool has been included to
identify reading and spoken comprehension ability of indi-
viduals and recommend the style of information that is
likely to best inform each individual. The tool also identi-
fies those participants whose aphasia severity is such that
they are unlikely to understand the information
sufficiently to provide informed consent and therefore
need the involvement of a carer, relative or legal represen-
tative. In addition, the reading deficits make completion of
standard questionnaire tools such as the EQ-5D difficult
and unreliable. We therefore developed and tested an ac-
cessible EQ-5D which uses illustrations and visually repre-
sented extent of difficulty.
There are three groups in the study. Introducing a
three-way comparison increases the required sample size
and therefore poses a potential threat to the power of
the study if recruitment is insufficient. However, a three-
way comparison is not required here as the first question
to answer is whether the computerised intervention is
more effective than usual care alone. Only if the answer
to the first question is positive is there a need to ask
whether it is the speech and language therapy compo-
nents that cause the effectiveness shown. In this case a
second comparison of computer intervention to activity
and/or attention control needs to be carried out. The
Hochberg analysis was chosen to allow for these con-
secutive comparisons, thus also maintaining a more
achievable sample size.
Finally, the set-up of 20 individual speech and lan-
guage therapy departments to participate in the study is
a considerable challenge, in which service support and
excess treatment costs must be negotiated at each site
independently, with a large range of local policies and fi-
nancial restrictions across the United Kingdom.
Trial status
The study has received ethical approval and fifteen partici-
pants have been recruited from the first five sites set up.
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